0,853  0,005  Caspase 9 stimulant
0,813  0,007  Antineoplastic (lung cancer)
0,811  0,008  Antineoplastic (breast cancer)
0,775  0,007  Antihypercholesterolemic
0,770  0,009  Antineoplastic (colorectal cancer)
0,759  0,009  Antineoplastic (colon cancer)
0,754  0,023  Apoptosis agonist
0,722  0,018  Transcription factor NF kappa B inhibitor
0,682  0,008  Antineoplastic (cervical cancer)
0,675  0,020  CYP3A4 substrate
0,646  0,005  Tubulin antagonist
0,671  0,036  Antiinflammatory
0,646  0,014  Prostate cancer treatment
0,630  0,009  NOS2 expression inhibitor
0,627  0,010  Cardiovascular analeptic
0,629  0,021  TNF expression inhibitor
0,606  0,011  Proliferative diseases treatment
0,599  0,021  CYP2C9 substrate
0,582  0,005  Antineoplastic (squamous cell carcinoma)
0,574  0,005  P-glycoprotein inhibitor
0,587  0,024  Antineoplastic (solid tumors)
0,566  0,013  AR expression inhibitor
0,561  0,009  Hypoxia-inducible factor 1 alpha inhibitor
0,559  0,011  Antipyretic
0,553  0,005  Hepatoprotectant
0,563  0,019  Antineoplastic (ovarian cancer)
0,557  0,015  UGT1A9 substrate
0,555  0,013  Antineoplastic (non-small cell lung cancer)
0,557  0,015  Cytostatic
0,567  0,029  Antileukemic
0,541  0,007  Antineoplastic (carcinoma)
0,541  0,010  Antimitotic
0,539  0,019  Antineoplastic (melanoma)
0,539  0,028  Teratogen
0,520  0,009  Antidiabetic symptomatic
0,526  0,018  Hepatic disorders treatment
0,497  0,005  Calcium channel activator
0,498  0,011  UGT2B4 substrate
0,504  0,024  Cytotoxic
0,479  0,005  Pneumotoxic
0,497  0,034  Immunosuppressant
0,486  0,030  CYP2C19 substrate
0,468  0,021  Antineoplastic (multiple myeloma)
0,490  0,044  Antibacterial
0,456  0,011  Antineoplastic (sarcoma)
0,466  0,026  Caspase 3 stimulant
0,442  0,004  Alpha tubulin antagonist
0,443  0,008  Topoisomerase II inhibitor
0,471  0,037  Aldehyde oxidase inhibitor
0,464  0,035  Embryotoxic
0,454  0,027  Antineoplastic (glioma)
0,450  0,028  Antineoplastic (brain cancer)
0,462  0,045  Antipruritic, allergic
0,444  0,028  Antioxidant
0,444  0,029  Antineoplastic (pancreatic cancer)
0,436  0,021  Nitric oxide antagonist
0,420  0,008  VCAM1 expression inhibitor
0,438  0,030  NOS3 expression inhibitor
0,422  0,016  RNA-directed DNA polymerase inhibitor
0,429  0,023  Antineoplastic (glioblastoma multiforme)
0,432  0,028  Sensitization
0,402  0,004  Beta tubulin antagonist
0,398  0,005  Antineoplastic antibiotic
0,415  0,022  UGT1A6 substrate
0,419  0,033  CTGF expression inhibitor
0,409  0,025  Antineoplastic (lymphoma)
0,415  0,035  Cardioprotectant
0,390  0,012  UGT2B7 substrate
0,420  0,044  Antiallergic
0,389  0,022  UDP-glucuronosyltransferase substrate
0,387  0,024  Antineoplastic (osteosarcoma)
0,390  0,029  Chemopreventive
0,379  0,020  Abortion inducer
0,382  0,024  Antineoplastic (endocrine cancer)
0,379  0,024  Sodium/bile acid cotransporter inhibitor
0,382  0,032  Mutagenic
0,377  0,033  Free radical scavenger
0,360  0,018  Contraceptive
0,367  0,026  Antiulcerative
0,345  0,006  Expectorant
0,350  0,012  UGT2B15 substrate
0,378  0,043  Lipoxygenase inhibitor
0,362  0,029  Antineoplastic (small cell lung cancer)
0,379  0,049  ICAM1 expression inhibitor
0,341  0,014  Genotoxic
0,334  0,010  DNA intercalator
0,337  0,014  Lipid peroxidase inhibitor
0,324  0,006  Topoisomerase II alpha inhibitor
0,353  0,037  Carcinogenic
0,324  0,013  Neurotrophic factor enhancer
0,339  0,029  Antineoplastic enhancer
0,349  0,041  DNA damaging
0,377  0,070  Ulceration
0,333  0,026  UGT1A1 substrate
0,327  0,026  UGT1A4 substrate
0,373  0,077  CYP2C19 inhibitor
0,314  0,019  Lipocortins synthesis antagonist
0,345  0,051  Antiosteoporotic
0,333  0,045  Antiprotozoal (Leishmania)
0,292  0,006  UGT2B10 substrate
0,320  0,034  Antineoplastic (bladder cancer)
0,349  0,066  Bone diseases treatment
0,303  0,021  UGT1A3 substrate
0,303  0,026  Antimutagenic
0,340  0,064  Antifungal
0,326  0,060  Spasmolytic
0,297  0,035  Tyrosine 3 hydroxylase inhibitor
0,282  0,024  Melanin inhibitor
0,330  0,072  Antithrombotic
0,321  0,066  Respiratory analeptic
0,276  0,024  Interferon gamma antagonist
0,271  0,028  Antipruritic, non-allergic
0,264  0,023  Protein kinase stimulant
0,305  0,066  CYP1A2 substrate
0,293  0,055  Antineoplastic (renal cancer)
0,322  0,086  Vasodilator, peripheral
0,261  0,026  Antineoplastic (gastric cancer)
0,244  0,010  Microtubule formation inhibitor
0,282  0,050  DNA synthesis inhibitor
0,251  0,020  Antineoplastic (bone cancer)
0,246  0,017  Topoisomerase I inhibitor
0,287  0,059  Tumour necrosis factor alpha release inhibitor
0,237  0,009  Arachidonic acid antagonist
0,287  0,062  Chemoprotective
0,241  0,018  Alkylator
0,293  0,072  5 Hydroxytryptamine release stimulant
0,269  0,048  Antihypertriglyceridemic
0,221  0,004  Acetylcholine release stimulant
0,292  0,080  Analeptic
0,223  0,015  Antieczematic
0,238  0,031  Amylase inhibitor
0,232  0,026  UGT2B9 substrate
0,270  0,074  GST M1-1 substrate
0,205  0,009  Antineoplastic (uterine cancer)
0,261  0,067  Antineoplastic (liver cancer)
0,199  0,004  UGT2B11 substrate
0,205  0,013  Antineoplastic alkaloid
0,285  0,096  Apoptosis antagonist
0,202  0,013  Androgen antagonist
0,244  0,059  Antihypotensive
0,251  0,066  Antineoplastic (lymphocytic leukemia)
0,304  0,121  Antiprotozoal
0,284  0,101  Vasodilator, coronary
0,245  0,063  Antiparasitic
0,216  0,039  Liver fibrosis treatment
0,254  0,077  5 Hydroxytryptamine uptake stimulant
0,203  0,031  Aldose reductase substrate
0,173  0,013  Contraceptive male
0,237  0,077  Vasodilator
0,171  0,012  Ca2+-transporting ATPase inhibitor
0,193  0,034  Antifungal enhancer
0,199  0,040  Antirickettsial
0,169  0,012  Antiviral (Trachoma)
0,167  0,010  Anabolic
0,175  0,021  Mucolytic
0,160  0,010  Aldose reductase inhibitor
0,162  0,012  Aromatase inhibitor
0,195  0,046  Toxic, respiratory center
0,155  0,007  Androgen agonist
0,263  0,116  Cholesterol antagonist
0,159  0,014  Antifungal (Pneumocystis)
0,212  0,067  Antiviral (Influenza)
0,177  0,032  Antitussive
0,207  0,064  Antihelmintic
0,167  0,023  Contraceptive female
0,198  0,056  LDLR expression enhancer
0,247  0,106  CYP2D6 inhibitor
0,189  0,048  Interleukin 6 antagonist
0,219  0,081  Cyclic AMP phosphodiesterase inhibitor
0,223  0,085  Antiamyloidogenic
0,184  0,046  Anesthetic
0,152  0,015  SULT1E1 substrate
0,158  0,023  Antiviral (Influenza B)
0,144  0,012  Postmenopausal disorders treatment
0,207  0,077  Nitric-oxide synthase stimulant
0,219  0,090  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,161  0,032  Coagulant
0,178  0,050  Heat shock protein 90 antagonist
0,162  0,033  Growth stimulant
0,222  0,093  Vascular (periferal) disease treatment
0,212  0,085  Peptidyltransferase inhibitor
0,156  0,033  SULT1A1 substrate
0,152  0,030  Photosensitizer
0,152  0,032  Choleretic
0,125  0,006  Topoisomerase II beta inhibitor
0,146  0,030  Sulfotransferase substrate
0,233  0,116  CYP2D6 substrate
0,167  0,052  Antiprotozoal (Coccidial)
0,173  0,060  Cholinergic
0,129  0,017  HIV-1 integrase (3'-Processing) inhibitor
0,161  0,049  Acetylcholinesterase inhibitor
0,224  0,113  Radiosensitizer
0,124  0,013  Estrogen agonist
0,126  0,015  HIV-1 integrase (Strand Transfer) inhibitor
0,133  0,023  Antibiotic
0,150  0,040  Cystathionine beta-synthase inhibitor
0,280  0,170  Antiarthritic
0,138  0,029  Estrogen antagonist
0,146  0,037  Endometrios treatment
0,168  0,061  Antiviral (Influenza A)
0,165  0,060  NOS3 expression enhancer
0,184  0,080  Sedative
0,173  0,074  Tumour necrosis factor antagonist
0,171  0,073  Sigma receptor agonist
0,143  0,046  Vanilloid 1 agonist
0,147  0,051  Cyclooxygenase 3 inhibitor
0,118  0,025  Interleukin 5 antagonist
0,129  0,035  Antiprotozoal (Toxoplasma)
0,101  0,008  SULT2A1 substrate
0,142  0,049  Cholesterol synthesis inhibitor
0,098  0,006  Lipocortins synthesis agonist
0,131  0,039  UGT2B1 substrate
0,146  0,055  Toll-Like receptor 2 antagonist
0,120  0,032  Estrogen receptor beta antagonist
0,111  0,024  Glycine receptor antagonist
0,094  0,008  Postcoital contraceptive
0,164  0,079  ATPase inhibitor
0,107  0,023  Dopamine D1 antagonist
0,168  0,083  Succinate dehydrogenase inhibitor
0,148  0,066  Adenylate cyclase stimulant
0,091  0,010  Estrogen receptor alpha agonist
0,125  0,043  Multidrug resistance-associated protein 1 inhibitor
0,234  0,155  Antiprotozoal (Plasmodium)
0,097  0,018  Antitreponemal
0,154  0,076  Eye irritation, high
0,130  0,057  Autism spectrum disorders treatment
0,101  0,027  CDC25A inhibitor
0,136  0,064  Interleukin 4 antagonist
0,102  0,032  Antiprotozoal activity enhancer
0,135  0,066  Skin whitener
0,076  0,007  Glucocorticoid antagonist
0,162  0,098  Antiviral (Hepatitis)
0,076  0,015  Dopamine D2 agonist
0,114  0,056  Electron transport complex I inhibitor
0,168  0,111  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,175  0,119  Antiviral (HIV)
0,088  0,032  Dopamine agonist
0,109  0,053  Chronic obstructive bronchitis treatment
0,135  0,079  Hair growth stimulant
0,076  0,021  Protein 50S ribosomal subunit inhibitor
0,090  0,035  Estrogen receptor alpha antagonist
0,123  0,068  Antiviral (Hepatitis B)
0,077  0,023  Heat shock protein 90 beta antagonist
0,105  0,051  Prolactin inhibitor
0,070  0,016  Glucose-6-phosphate translocase inhibitor
0,069  0,015  Pregnane X receptor antagonist
0,158  0,105  Anesthetic general
0,186  0,135  Radioprotector
0,169  0,119  VEGF expression inhibitor
0,093  0,044  Inducible nitric-oxide synthase inhibitor
0,120  0,074  Antiseptic
0,063  0,018  Dopamine D5 antagonist
0,112  0,067  Monophenol monooxygenase inhibitor
0,123  0,080  Antihemorrhagic
0,151  0,107  Amyloid beta aggregation inhibitor
0,057  0,015  Progesterone antagonist
0,045  0,005  Glucocorticoid agonist
0,086  0,046  T cell inhibitor
0,205  0,166  CYP3A4 inhibitor
0,094  0,056  Paget's disease treatment
0,069  0,032  Transcription factor RelA inhibitor
0,058  0,021  Estradiol 17 beta-dehydrogenase inhibitor
0,064  0,028  Ryanodine receptor antagonist
0,081  0,045  Narcotic antagonist
0,050  0,016  Hypogonadism treatment
0,039  0,005  Dopamine D1 agonist
0,081  0,049  Na+ K+ transporting ATPase inhibitor
0,074  0,043  HIV-1 integrase inhibitor
0,083  0,055  Thioredoxin reductase inhibitor
0,115  0,087  Gastritis treatment
0,125  0,099  SULT1A3 substrate
0,082  0,056  Ca(v)3.1 blocker
0,227  0,201  Alpha-glucosidase inhibitor
0,067  0,043  Hypercalcemia treatment
0,132  0,108  Heat shock protein 90 alpha antagonist
0,144  0,121  Cardiodepressant
0,208  0,185  FMO1 substrate
0,029  0,007  Corticosteroid-like
0,250  0,229  5 Hydroxytryptamine release inhibitor
0,068  0,048  Andropause treatment
0,125  0,107  Antidiarrheal
0,085  0,066  ATPase (Vacuolar H+) inhibitor
0,051  0,032  Factor III inhibitor
0,202  0,184  GST A substrate
0,080  0,062  Antispirochetal
0,110  0,093  Antihyperlipoproteinemic
0,040  0,023  Vesicle monoamine transporter inhibitor
0,098  0,081  DOPA decarboxylase inhibitor
0,042  0,025  Dopamine D5 agonist
0,122  0,105  Skeletal muscle relaxant
0,036  0,020  Tubulin agonist
0,149  0,135  Insulin sensitizer
0,060  0,046  Antimycoplasmal
0,145  0,132  Phobic disorders treatment
0,103  0,091  Interleukin 8 antagonist
0,021  0,009  Antibiotic Anthracycline-like
0,069  0,058  Glycine receptor agonist
0,149  0,138  Hypolipemic
0,098  0,088  Carcinogenic, group 3
0,021  0,011  Progesterone receptor B antagonist
0,129  0,119  Muscular dystrophy treatment
0,114  0,105  Neurotrophic factor
0,030  0,021  RNA-directed RNA polymerase stimulant
0,108  0,100  NADPH oxidase inhibitor
0,148  0,140  CYP2B6 inhibitor
0,091  0,084  Alpha 2b adrenoreceptor antagonist
0,016  0,010  Antibiotic Tetracycline-like
0,109  0,104  Antihelmintic (Trematoda)
0,073  0,069  Opioid kappa receptor antagonist
0,129  0,126  Carcinogenic, group 1
0,028  0,024  Estrogen receptor beta agonist
0,080  0,076  Granulocyte macrophage colony stimulating factor agonist
0,208  0,205  15-Lipoxygenase inhibitor
0,125  0,123  Uterine stimulant
0,026  0,024  Hedgehog signaling activator
0,128  0,127  Antipruritic
0,036  0,035  Vanilloid 3 antagonist
0,090  0,090  Toll-Like receptor 4 antagonist

